Auxilius’ innlegg

Advisory

Portfolio analysis = marketplace success? Informed assessments of variables is essential to efficient development strategy, which can increase the likelihood of success. Premier Consulting's experienced team helps to align sponsors' business goals with regulatory requirements. Learn more: https://bit.ly/3A2a1pg #PortfolioAnalysis #ProductDevelopment

In case you missed it, Silo recently filed a provisional patent with the USPTO. The patent, titled ‘Methods and Combinations for Managing Pain,’ includes protection for SP-26, our implantable drug delivery system for a novel time-released, dose-controlled formulation of #ketamine, initially targeted for #fibromyalgia. In pre-clinical studies, Silo has reported positive stability of SP-26 for time-release and dosage control. The next tests of the SP-26 ketamine implant will measure drug dissolution and time-release action. More: https://bit.ly/43mM5JG #Science #Biotech #Psychedelics #PsychedelicResearch #Biotechnology

🌍 In the global shift towards financial agility, companies like Handelsbanken, Bayer Pharmaceuticals, and Roche Pharmaceuticals are embracing Beyond Budgeting, and the results are truly astonishing.  A Boston Consulting Group survey of 174 CFOs in organisations adopting Beyond Budgeting principles found that:  • sales are up (59% of respondents agreed)  • costs are down and resources are saved (56%)  • better business decisions are made (52%)  • performance management is more effective (51%)  Our world is evolving rapidly, yet these businesses show that embracing change can lead to a competitive edge and a redefined future. Find out more in our blog https://lnkd.in/ew8GPgnQ #BeyondBudgeting

🖥 Data. We all rely on it in one way or another, especially in Life Science research and trials. 💰 Do you make the most of its value though? 🤔 Ever tried calculating how much it's worth? 🤑 It's easier than you think and can help you get more funding and increase the value of your work. Don't know how? I've got you covered. Would love to hear your thoughts. Drop a comment below. #DataScience #LifeSciences #ResearchAndDevelopment #DataValuation #Funding #Innovation #DataDrivenDecisionMaking #ClinicalTrials #Biotechnology #Pharmaceuticals #HealthcareInnovation #DataAnalysis #BigData #ScienceCommunication #ResearchFunding #stem

Companies with exceptional organic growth and well-integrated business units in outsourced pharma services, healthcare IT, payer technology and services, medical products and devices, and a variety of provider subsectors were prioritized by buyers in 2023. Our 2024 Healthcare & Life Sciences Outlook report reflects on examples of several trends that initiated rising momentum over the past year and highlights the appealing categories where we anticipate an increase in investor activity to come.

Companies with exceptional organic growth and well-integrated business units in outsourced pharma services, healthcare IT, payer technology and services, medical products and devices, and a variety of provider subsectors were prioritized by buyers in 2023. Our 2024 Healthcare & Life Sciences Outlook report reflects on examples of several trends that initiated rising momentum over the past year and highlights the appealing categories where we anticipate an increase in investor activity to come.

Companies with exceptional organic growth and well-integrated business units in outsourced pharma services, healthcare IT, payer technology and services, medical products and devices, and a variety of provider subsectors were prioritized by buyers in 2023. Our 2024 Healthcare & Life Sciences Outlook report reflects on examples of several trends that initiated rising momentum over the past year and highlights the appealing categories where we anticipate an increase in investor activity to come.

💡In the realm of life sciences, data isn't just information; it's the key to unlocking groundbreaking discoveries 📊📘 At Genestack, we're redefining the game by proposing a formula that makes the intangible tangible 🌐🔍 This ebook isn't just about data; it's about understanding the true value of your life sciences data. 🚀 Highlights Include: 🌱 Strategies for Efficient Data Acquisition 🔐 Best Practices in Data Storage and Security 🔄 Unlocking the Power of Data Integration 📈 Leveraging Advanced Analytics for Informed Decision-Making Let's start a conversation! 💬 What challenges do you face in valuing your life sciences data? Share your thoughts, and experiences, and let's discuss how this formula can revolutionize your approach.

Did you know that there are incentives for businesses who develop medications and treatments for rare diseases that affect small populations? The orphan drug credit is a federal tax credit that helps pharmaceutical companies focus on saving lives while reducing financial stress so they can support people and their well-being in society. https://lnkd.in/gpcpHmF2 #lifesciences #biotechnology #pharmaceutical #tax #researchanddevelopment #taxcredits